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Autism is a childhood neuropsychiatric disorder that, despite exhibiting high heritability, has largely eluded efforts to identify speciﬁc
genetic variants underlying its etiology. We performed a two-stage genetic study in which genome-wide linkage and family-based asso-
ciation mapping was followed up by association and replication studies in an independent sample. We identiﬁed a common polymor-
phism in contactin-associated protein-like 2 (CNTNAP2), a member of the neurexin superfamily, that is signiﬁcantly associated with au-
tism susceptibility. Importantly, the genetic variant displays a parent-of-origin and gender effect recapitulating the inheritance of autism.Autistic disorder (MIM 290850), ﬁrst described by Kanner
in 1943,1 is a pervasive developmental disorder character-
ized by a triad of marked features: impaired social interac-
tion, impaired language development, and restricted and
repetitive behavior and interests. A diagnosis of autism
can typically be made by 4 years of age. The prevalence is
approximately 20 per 10,000 for autistic disorder and 60
per 10,000 individuals for all autism spectrum disorders,
with males being 4 times as likely, as compared to females,
to be affected.2 There is no doubt that autism presents a
signiﬁcant disease burden.
Compelling evidence for a genetic basis for autism has
been provided by twin studies, demonstrating a signiﬁ-
cantly higher concordance rate for monozygous versus di-
zygous twins, with an overall heritability of 80%–90%.3
Consequently, it is expected that appropriate genomic
screens can identify susceptibility genes given the major
genetic component to familiality. With the availability of
new genotyping technologies that can survey the genome
at far higher resolution than before and large family collec-
tions with sufﬁcient samples for both discovery and valida-
tion, we initiated a two-stage genome-wide study of autism
that is not limited by our current understanding of autism
pathophysiology.
For stage I, we selected 72 multiplex families (68 with 2
affected children and 4 with 3 affected children) compris-
ing 148 affected offspring and 292 individuals. We attemp-
ted to reduce phenotypic heterogeneity and increase the
genetic contribution by requiring all affected individuals
to be positive for autism on both ADI-R and ADOS instru-
ments4 and to have onset <36 months. This sampling was
in contrast to accepting only an ADI-R classiﬁcation of au-
tism or accepting the broader ADOS classiﬁcation of au-
tism spectrum disorder. No previously reported genetic
study of autism has had similarly strict phenotypic inclu-
sion criteria and equivalent sample size. All samples were
obtained from the National Institute of Mental Health
(NIMH) Autism Genetics Initiative.160 The American Journal of Human Genetics 82, 160–164, JanuaryWe genotyped all samples by using Affymetrix 500K ar-
rays with genotypes inferred via the Affymetrix BRLMM
genotyping algorithm at the default settings. We used rel-
atively stringent quality control cut-offs for including
SNPs in our analyses, because even moderate missing
data or error rates increase false-positive linkage and fam-
ily-based association tests such as the transmission disequi-
librium test (TDT).5 Speciﬁcally, SNPs with >10% missing
data, >1% Mendelian error, and lack of ﬁt to Hardy-Wein-
berg proportions (p < 0.001) were excluded from analysis,
leaving 72% (336,121 of 468,411) of the data on autosomal
SNPs for further analysis. One family was excluded because
of Mendelian errors arising frommaternal incompatibility,
and one child was excluded because he was incompatible
with both parents, resulting in 78 sib-pairs and 145 par-
ent/child trios that we included in the analyses.
Genome-wide association analysis with the TDTwas per-
formed for both single-SNP and haplotypes with EATDT,6
and no genome-wide signiﬁcant SNPs or haplotypes were
identiﬁed. However, under a scenario in which multiple
unlinked variants within a locus contribute to autism
susceptibility, as opposed to a single variant of large effect,
the incorporation of traditional linkage data can be of
great beneﬁt. Indeed, genome-wide linkage analysis by
MERLIN7 revealed two loci with LOD scores above 2: one
at chromosome 7q35 (maximum LOD score 3.4 at 151.4–
154.4 cM; Figure 1A) and the second at chromosome
10p13–14 (maximum LOD score 2.9 at 26.6–34.5 cM).
The peak at 7q35 is genome-wide signiﬁcant and is a novel
ﬁnding for strictly deﬁned autism, though it is in the same
region that has been previously identiﬁed as a possible lan-
guage quantitative trait locus (QTL) in autism families.8
TDT in the 1-LOD genetic interval under the chromosome
7q35 linkage peak revealed a single SNP, rs7794745, with
signiﬁcant association with autism (p < 2.14 3 105)
(Figure 1B), even after correcting for the number of SNPs
tested under the linkage peak by permutation (p <
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observed Mendelian errors, and was in Hardy-Weinberg
equilibrium (p ¼ 0.98). These genotypes were then inde-
pendently validated by TaqMan assays. The T allele at
SNP rs7794745 is overtransmitted with a transmission fre-
quency of t ¼ 0.68. This SNP is a common polymorphism
with minor allele frequency of 0.36 and resides in the in-
tron between exons 2 and 3 of the CNTNAP2 gene (Fig-
ure 2). CNTNAP2 (MIM 604569), or contactin-associated
protein-like 2, is a large gene spanning 2.5 Mb and encodes
a member of the neurexin family9 that are known to medi-
ate cell-cell interactions in the nervous system. CNTNAP2
protein is localized at the juxtaparanodes of myelinated
axons andmay be involved in axon differentiation.10 Con-
sequently, it is an excellent candidate gene for autism.
To validate this initial ﬁnding, we genotyped an inde-
pendent sample of 1295 parent-child trios from the
NIMH Repository for rs7794745 and again found over-
transmission of the T allele (p < 0.005). Genotyping was
Figure 1. Genome-wide Linkage and
Association Studies in Autism
(A) Linkage studies were conducted in 72
multiplex families from the NIMH Reposi-
tory and yielded a single significant result
on chromosome 7q35.
(B) Family-based association test (TDT) re-
sults in 145 trios, from the families in (A),
for the 1-LOD interval (marked by a red bar)
under the linkage peak. Genomic position
is on the x axis (cM, centiMorgan; Mb,
megabase) and the negative base-10 loga-
rithm of the p value on the y axis.
performed with TaqMan assays and
we obtained 98.5% complete data
with no observed Mendelian errors
or deviation from Hardy-Weinberg
equilibrium (p ¼ 0.83). The minor al-
lele frequency was 0.38, similar to
that observed in stage I, but the ge-
netic effect was smaller (t ¼ 0.54). It
is important to note that our stage II
samples used a broader deﬁnition of
autism (ADI-R-positive without re-
quiring ADOS classiﬁcation of either
autism or autism spectrum disorder)
than in stage I, increasing phenotypic
heterogeneity, and this may explain
the reduced strength of the effect of
rs7794745. However, when we ex-
amined 145 multiplex families (303
affected children) from stage II corre-
sponding to the same selection crite-
ria as stage I, the strength of the effect
was no different than the remainder
of the stage II samples (data not
shown), suggesting that the strength
of the effect seen in stage I likely reﬂects a ‘‘winner’s curse’’
and is an overestimate of the true effect. Nevertheless, a
signiﬁcant overtransmission of the T allele is observed in
two independent family-based samples, conﬁrming that
CNTNAP2 is an autism-susceptibility gene. Additional
studies incorporating speciﬁc domains of autism may
shed light on which speciﬁc autistic phenotypes are associ-
ated with variation in CNTNAP2, because heterogeneity in
the genetic effect is observed.
To further characterize the genetic properties of
rs7794745, we examined transmission stratiﬁed by paren-
tal gender andbyoffspring gender given themarked sex dif-
ference in the incidence of autism. As shown in Table 1, the
overall transmission frequency (t ¼ 0.55: p < 7.35 3 105)
is signiﬁcantly greater from mothers (t ¼ 0.61) than from
fathers (t¼ 0.53) in the combined sample, and this parent-
of-origin difference is signiﬁcant (p < 0.001). Interestingly,
this genetic effect and difference is largely observed inThe American Journal of Human Genetics 82, 160–164, January 2008 161
affected males than females, although the rarity of affected
females implies that the power to detect the observed differ-
ence in females is low. To estimate the genetic effect of the
T allele, we focused on stage II results, because they are
unlikely to reﬂect any winner’s curse and have assumed
a normally distributed, but unobservable, liability scale
with a threshold determining affectation status.11 Pene-
Figure 2. Fine Mapping of CNTNAP2
The top panel shows the results of associa-
tion tests in 1440 trios with significance
for each SNP shown as the negative base-10
logarithm of the p value on the y axis plot-
ted against genomic position in megabase
(Mb) on the x axis. The CNTNAP2 exons 2
and 3 are shown in orange. The bottom
panel shows all pairwise associations be-
tween 11 SNPs at the CNTNAP2 locus. The
value within each diamond is the linkage
disequilibrium statistic D0. Diamonds with-
out a number correspond to D0 ¼ 1; shading
represents the magnitude and significance
of pair-wise linkage disequilibrium (LD)
with a red-to-white gradient reflecting
higher to lower LD values (see Haploview
online for further details).
Table 1. Transmission of the CNTNAP2 Genetic Polymorphism
rs7794745 to Affected Children
n
A
Allele
T
Allele t tM tP p p*
Stage I 137 44 93 0.68 0.75 0.67 2.14 3
105
2.58 3
105
Stage II 1219 561 658 0.54 0.59 0.51 0.005 0.003
Combined 1356 605 751 0.55 0.61 0.53 7.35 3
105
0.001
Males 1077 468 609 0.57 0.64 0.53 1.74 3
105
3.75 3
104
Females 279 137 142 0.51 0.51 0.51 0.77 0.93
n is the total number of transmissions; t is the transmission frequency of
the T allele; tM and tP refer to maternal and paternal transmission frequen-
cies, respectively; and p and p* refer to the overall significance of t and the
significance of the parent-of-origin effect, respectively.
trances were then estimated under
Morton and Mclean’s mixed model
of inheritance,12 assuming a preva-
lence of 0.0032 in males and 0.0008
in females (overall prevalence of
1:500, males 4 times as likely to be af-
fected), and the relative risk stratiﬁed
by rs7794745 genotype and sex is
shown in Figure 3. Our data are com-
patible with the hypothesis that the
common variant we detect is a disease
variant only when inherited through
the female germline. The cause of
this biased transmission is unclear, because a null paternal
allele of CNTNAP2 is associated with obsessive-compulsive
disorder,13 suggesting that the paternal allele is normally
expressed. Our ﬁnding of a parent-of-origin bias in the ge-
netic effect is intriguing and needs to be replicated by other
studies. Nevertheless, differential genetic effects from the
two parents are not unexpected in complex diseases with
a sex difference.14
In an attempt to ﬁne-map the functional variant in
CNTNAP2 contributing to the observed association with
autism, we genotyped 10 additional SNPs ﬂanking
rs7794745 in the combined stage I and II samples. These
SNPs were chosen to tag the LD block containing
rs7794745 based on data from the HapMap CEU popula-
tion. No single SNP showed greater signiﬁcance than
rs7794745 (Figure 2), and no haplotypes showed a marked
increased in signiﬁcance (data not shown), suggesting that
either rs7794745, or any other variant highly correlated
with it, may be candidates or surrogates for the functional
variant.
Our ﬁndings are particularly intriguing in light of the
recent study by Strauss and colleagues who linked recessive
loss-of-function alleles of CNTNAP2 with cortical dyspla-
sia-focal epilepsy (CDFE [MIM 610042]); 67% of the162 The American Journal of Human Genetics 82, 160–164, January 2008
children with CDFE are also diagnosed with autism.15
CNTNAP2 is a very large gene spanning more than 2.5 Mb
and maps to a region of chromosomal fragility.16 Conse-
quently, it is possible that additional variants in this gene,
including genomic copy number alterations, could also
contribute to autism. Indeed, two additional genetic studies
in this issue of AJHG, one identifying an association with
a rare nonsynonymous variant17 and one demonstrating
an association with common variants and the language
component of autism,18 also point to CNTNAP2 as an
autism-susceptibility gene.
Given that Alarco´n and colleagues also identiﬁed a com-
mon noncoding variant in CNTNAP2,18 and there is some
overlap in samples, it is important to highlight the inde-
pendent yet complementary nature of our two ﬁndings.
First, different phenotypes were studied, with Alarco´n
and colleagues focusing on a quantitative trait, ‘‘age at ﬁrst
word,’’ whereas we used a qualitative strict autism diagno-
sis. Second, although 70/72 families from our stage I sam-
ple were included in the Alarco´n study, 2/3 of our stage II
samples were nonoverlapping. Even after exclusion of all
overlapping samples from our stage II data, rs779475 was
still signiﬁcantly associatedwith autism (p< 0.05), demon-
strating the independence of this association. Third, and
most importantly, the variants identiﬁed in both studies
are more than 1 Mb apart and show no evidence of linkage
disequilibrium, indicating that despite being in the same
gene and exhibiting a male-speciﬁc bias, these are truly
independent loci providing independent evidence for asso-
ciation of common noncoding variants in CNTNAP2 with
autism susceptibility. Indeed, the combined evidence from
all three studies strongly suggests the existence of alleleic
heterogeneity that needs to be addressed fully by genotyp-
Figure 3. Relative Risk of rs7794745 Genotype Stratified
by Sex
The first allele of each genotype represents the paternal allele, and
the second allele represents the maternal allele. Relative risk is
compared to the sex-specific population risk, assuming overall
prevalence of 1:500 and males 4 times more likely to be affected
than females. The bars indicate 95% confidence intervals.The Aming all samples with the same sets of markers and sequenc-
ing all coding exons.
In conclusion, we identiﬁed a common variant in
CNTNAP2 that is associated with increased risk for autism
in two independent family-based samples and exhibits
a parent-of-origin bias. Furthermore, given the strength
of our initial linkage signal, it is likely that additional
genetic variants in this gene that contribute to autism
susceptibility remain to be discovered.
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